New award for ropinirole HCL tablets with solco healthcare US, LLC. Period of performance is 9/28/2026 - 9/27/2027
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0032
- Awardee
-
Solco Healthcare US LLC UEI JN2QZJD6PKM9
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Ropinirole Tablet Pre-Solicitation · 36E79726R0019 · Posted Apr 9, 2026
- Last date to order 5% complete
- IDV ceiling
- $8,554,884.05
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded a single-award indefinite-delivery contract to Solco Healthcare US LLC on September 28, 2026, for Ropinirole HCL Tablets with a ceiling of $8,554,884.05. The contract carries no set-aside designation.
Place of performance serves the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's Pharmaceutical Prime Vendor Programs. The contract procures Ropinirole HCL tablets in multiple strengths (0.25 mg through 5 mg) and package configurations (100 or 500 tablets per bottle), with estimated annual requirements of approximately 176,000 bottles across 13 line items. This is a commercial item acquisition under FAR Part 12.
The period of performance runs from September 28, 2026, through September 27, 2027, with four one-year option periods extending through 2030. NAICS 325412 applies (Pharmaceutical Preparation Manufacturing), along with PSC 6505 (Drugs and Biologicals). The contract was issued under RFP 36E79726R0019, which sought a single responsible offeror capable of providing an uninterrupted source of supply. A modification incorporated Section 5 of Executive Order 14398, Clause 52.222-90, addressing diversity, equity, and inclusion discrimination prohibitions, effective April 2026.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0032?
36E79726D0032 was awarded to Solco Healthcare US LLC by National Acquisition Center (Headquarters) on September 28, 2026.
How much is contract 36E79726D0032 worth?
36E79726D0032's own ceiling is $8,554,884.
Who can order from contract 36E79726D0032?
36E79726D0032 is a single award indefinite delivery contract.
Was contract 36E79726D0032 competed?
The extent of competition for 36E79726D0032 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV